Ultrahigh throughput total transcriptomics

在提交了专利(由UCAM的技术转移办公室Cambridge Enterprise支持)后，我们现在希望探索一条详细的商业化路径，包括针对目标市场和客户的战略，进一步探索知识产权格局，并为各种场景起草商业计划，以量化其作为收入来源的生存能力。在概念验证实验中，我们将提高吞吐量和数据质量，以评估和展示VASA-Drop在扩展的微流体工作流程中的未来潜力。最后，我们将通过探索如何将Vasa-Drop用作细胞培养实验的质量控制读数来定义一个新的应用领域。

Having submitted a patent (supported by CambridgeEnterprise, UCAM's technology transfer office) we now want to explore a detailed commercialization pathway, including a strategy totarget markets and customers, further exploration of the IP landscape and draft business plans for various scenarios to quantify theirviability as revenue streams. In proof-of concept experiments we will increase throughput and data quality to assess and showcasethe future potential of VASA-drop in an extended microfluidic workflow. Finally we will define a new area of application by exploringhow VASA-drop can be used as a quality control readout for cell culture experiments.